|Articles|January 21, 2022
Orphan Drug Development – A pragmatic approach to developing a rare disease drug
Author(s)Curia (formerly AMRI)
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
3
Six-Month eCOA Timelines Signal Need for Earlier Planning
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5